Sagimet Announces Oral Presentation of Data from the Phase 2b FASCINATE-2 … – Morningstar

SAN MATEO, Calif., May 07, 2024 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company …

Continue

Do you trust this headline?

Based on recent headline ratings, 100% of this readership currently trusts the local media, which has an average score of 84% regionally and is currently trending positivepositive.

100%

Media Trust Score100%

Read All

In

News